Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Long-Term Investments (2019 - 2025)

Historic Long-Term Investments for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $1.0 million.

  • Pharming's Long-Term Investments fell 108.27% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 108.27%. This contributed to the annual value of $466000.0 for FY2024, which is 7960.61% down from last year.
  • Per Pharming's latest filing, its Long-Term Investments stood at $1.0 million for Q3 2025, which was down 108.27% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Pharming's Long-Term Investments ranged from a high of $7.6 million in Q2 2022 and a low of $6720.0 during Q1 2021
  • For the 5-year period, Pharming's Long-Term Investments averaged around $2.5 million, with its median value being $1.5 million (2023).
  • Within the past 5 years, the most significant YoY rise in Pharming's Long-Term Investments was 9854583.33% (2022), while the steepest drop was 9989.73% (2022).
  • Pharming's Long-Term Investments (Quarter) stood at $7267.6 in 2021, then surged by 34312.78% to $2.5 million in 2022, then fell by 8.64% to $2.3 million in 2023, then plummeted by 79.61% to $466000.0 in 2024, then surged by 115.67% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $672000.0 during Q1 2025.